Vincerx Pharma
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $1,314 |
Gross Profit | -270 | -264 | 1,056 |
EBITDA | -7,096 | -7,214 | -5,275 |
EBIT | -7,366 | -7,478 | -5,533 |
Net Income | -1,808 | -12,429 | -4,950 |
Net Change In Cash | 0 | 0 | 1,314 |
Free Cash Flow | -5,828 | -7,739 | -8,019 |
Cash | 8,005 | 5,192 | 12,854 |
Basic Shares | 38,339 | 21,400 | 21,407 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -915 | -939 | -340 | -172 |
EBITDA | -42,609 | -68,668 | -62,656 | -10,714 |
EBIT | -42,661 | -69,607 | -62,996 | -10,714 |
Net Income | -40,157 | -57,160 | -15,608 | -10,730 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 61,792 | |||
Free Cash Flow | -40,453 | -59,604 | -38,660 | -2,279 |
Cash | 12,782 | 11,663 | 111,459 | 61,792 |
Basic Shares | 21,295 | 21,029 | 17,176 | 13,984 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.17 |
2024-06-30 | -$0.05 |
2024-03-31 | -$0.58 |
2023-12-31 | -$0.23 |
